Holen Sie sich die Stockscreener-App
84.52
1.21%
-1.398
Handel nachbörslich:
83.00
-1.522
-1.80%
Schlusskurs vom Vortag:
$85.92
Offen:
$86.6
24-Stunden-Volumen:
698.99K
Relative Volume:
1.45
Marktkapitalisierung:
$3.89B
Einnahmen:
$305.11M
Nettoeinkommen (Verlust:
$-196.00K
KGV:
-13,003.38
EPS:
-0.0065
Netto-Cashflow:
-
1W Leistung:
+3.15%
1M Leistung:
+0.17%
6M Leistung:
-33.61%
1J Leistung:
+0.00%
1-Tages-Spanne:
$80.27
$86.60
1-Wochen-Bereich:
$78.01
$87.87
52-Wochen-Spanne:
$61.96
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Firmenname
Billiontoone Inc
Sektor
Branche
Telefon
650-460-2551
Adresse
1035 O'BRIEN DRIVE, MENLO PARK
Compare BLLN vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
84.52 | 3.95B | 305.11M | -196.00K | 0 | -0.0065 |
TMO
Thermo Fisher Scientific Inc
|
448.27 | 166.59B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.86 | 121.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.15 | 44.12B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
338.72 | 33.62B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.09 | 32.49B | 7.07B | 1.29B | 993.00M | 4.5355 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2025-12-01 | Eingeleitet | BTIG Research | Buy |
| 2025-12-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-12-01 | Eingeleitet | Jefferies | Hold |
| 2025-12-01 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-01 | Eingeleitet | Stifel | Buy |
| 2025-12-01 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-12-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Billiontoone Inc Aktie (BLLN) Neueste Nachrichten
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect? - Zacks Investment Research
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
Transcript : BillionToOne, Inc., Q1 2026 Earnings Call, May 06, 2026 - marketscreener.com
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
BillionToOneStarting 2026 Strong (NASDAQ:BLLN) - Seeking Alpha
BLLN Stock Price, Quote & Chart | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Jim Cramer on BillionToOne: “I Say Buy It” - Insider Monkey
BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells - Clinical Lab Products
BillionToOne's (NASDAQ:BLLN) Strong Earnings Are Of Good Quality - 富途牛牛
Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care StockBillionToOne (NASDAQ:BLLN), Desi - Benzinga
Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock - Sahm
Cramer's lightning round: Buy BillionToOne - MSN
BillionToOne (NASDAQ:BLLN) Momentum Fuels Nasdaq Healthcare Interest - Kalkine Media
BillionToOne (BLLN) NeoTribe funds shift 465,607 shares in internal move - Stock Titan
Fund and trust transfers reshape BillionToOne (BLLN) share stake - Stock Titan
Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $120 - Moomoo
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Yahoo Finance
BillionToOne's (NASDAQ:BLLN) Earnings May Just Be The Starting Point - simplywall.st
Solid Earnings Reflect BillionToOne's (NASDAQ:BLLN) Strength As A Business - Yahoo Finance
Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress - Investing.com Nigeria
Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress By Investing.com - Investing.com South Africa
BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability By Investing.com - Investing.com South Africa
Why BillionToOne Stock Is Suddenly Sliding - TipRanks
BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability - Investing.com
Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps - Investing.com
Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps By Investing.com - Investing.com Nigeria
BillionToOne Stock 5-Day Winning Spree: Stock Climbs 47% - Trefis
5-Day Rally Sends BillionToOne Stock Up 47% - Trefis
Why BillionToOne Shares Are Suddenly Soaring - TipRanks
TradingKey - TradingKey
BillionToOne (BLLN) reports Q1 earnings: What key metrics have to say - MSN
Wall Street analysts predict a 25.63% upside in BillionToOne (BLLN): Here's what you should know - MSN
Discover May 2026's Top Stocks Estimated Below Intrinsic Value - Sahm
AI Model Lifts Score on BillionToOne (BLLN) After Earnings Turnaround - TipRanks
Number of shareholders of BillionToOne, Inc. – NASDAQ:BLLN - TradingView
BillionToOne, Inc. (BLLN) Eps Diluted (TTM) - Zacks Investment Research
Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know - Yahoo Finance
BTIG Sticks to Their Buy Rating for BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH) - The Globe and Mail
Billiontoone (NASDAQ:BLLN) Price Target Raised to $125.00 at JPMorgan Chase & Co. - MarketBeat
Illumina Patent Lawsuit Targets BillionToOne Prenatal Tests (1) - Bloomberg Law News
Billiontoone (NASDAQ:BLLN) Shares Up 10.6% Following Better-Than-Expected Earnings - MarketBeat
BillionToOne, Inc. Reports Strong Q1 2026 Revenue Growth and Profitability in Latest 10-Q Filing - Minichart
Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130 - Moomoo
A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145 - Moomoo
BTIG Research Issues Pessimistic Forecast for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BillionToOne, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BillionToOne Q1 2026 slides: 84% revenue surge, 73% gross margin By Investing.com - Investing.com Australia
Earnings call transcript: BillionToOne’s Q1 2026 revenue surges 84% YoY By Investing.com - Investing.com South Africa
Finanzdaten der Billiontoone Inc-Aktie (BLLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):